Researchers Take Action to End Airlines’ Restrictions on Lab Animals

United Airlines, British Airways, China Southern Airlines, and Qatar Airways face a formal complaint over their refusal to transport animals for scientific research.

Written byKatarina Zimmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE, © ISTOCK, BOARDING1NOW

In a recently filed complaint to the US Department of Transportation, the National Association for Biomedical Research accuses four major airlines of illegally discriminating against customers wishing to fly animals destined for the lab. The practice is unlawful, the complaint argues, because the airlines agree to carry the same species for zoos, pets, and other purposes.

“The prohibition on the carriage of research animals [slows] down the progress of essential and life-saving research that is necessary for drugs, treatments, cures and the prevention of disease,” writes National Association for Biomedical Research (NABR) President Matthew Bailey in an email to The Scientist.

For instance, Pennsylvania-based Covance Research Products, a contract research organization that imports animals from Asia, has to rely on “only a select few airlines continuing to offer very limited, and often circuitous, routes that add time and cost,” according to the complaint.

Within the US, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies